SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sept. 18, 2006--Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, announced today that Mark Ahn, PhD, President & Chief Executive Officer, will present a company update at the UBS Global Life Sciences Conference on Monday, September 25th at 11:00am EDT at The Grand Hyatt at Grand Central Station, New York, NY.
